glp 1 in louisiana Study finds GLP-1 drugs may reduce risk of more than a dozen cancers, offering hope where obesity-related cancer rates are high, Meg Farris reports. Louisiana Medicaid coverage for obesity

A recent nested case-control study based on a French national health insurance system database reported a significant association between thyroid cancer and GLP1 receptor agonist use (hazard ratio 1.46, 95% confidence interval 1.23 to 1.74).7 However, the comparator in that study was non-use of GLP1 receptor agonists, rather than an active comparator

CagriSema is predicted at $1,400-1,600/month compared to Wegovy's $1,349

While pills struggle with absorption, IV delivery sends pure antioxidant power straight to your cells

The anti-aging properties of GHK-Cu reflect its fundamental role in maintaining tissue homeostasis and counteracting age-related decline in regenerative capacity